Prestige Consumer Healthcare
PBH
#3940
Rank
HK$23.30 B
Marketcap
HK$473.46
Share price
1.27%
Change (1 day)
-27.83%
Change (1 year)

Prestige Consumer Healthcare (PBH) - Total debt

Total debt on the balance sheet as of September 2025 : HK$8.10 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's total debt is HK$8.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Prestige Consumer Healthcare - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2025-03-31HK$8.12 B-8.91%
2024-03-31HK$8.91 B-16.9%
2023-03-31HK$10.73 B-9.06%
2022-03-31HK$11.80 B0.21%
2021-03-31HK$11.77 B-14.01%
2020-03-31HK$13.69 B-3%
2019-03-31HK$14.11 B-9.74%
2018-03-31HK$15.64 B-8.25%
2017-03-31HK$17.04 B35.24%
2016-03-31HK$12.60 B4.15%
2015-03-31HK$12.10 B67.01%
2014-03-31HK$7.24 B-3.84%
2013-03-31HK$7.53 B-13.63%
2012-03-31HK$8.72 B130.4%
2011-03-31HK$3.78 B50.46%
2010-03-31HK$2.51 B-14.14%
2009-03-31HK$2.93 B-8.37%
2008-03-31HK$3.19 B-11.61%
2007-03-31HK$3.62 B-6.82%
2006-03-31HK$3.88 B0.61%
2005-03-31HK$3.86 B233.56%
2004-03-31HK$1.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
GlaxoSmithKline
GSK
HK$185.75 B 2,192.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$473.67 B 5,745.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
HK$51.23 B 532.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.49 B 4,299.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$15.17 M-99.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$249.27 B 2,976.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
HK$279.82 B 3,352.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$636.40 B 7,753.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$23.96 B 195.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$100.74 B 1,143.11%๐Ÿ‡บ๐Ÿ‡ธ USA